Recent analyst upgrades around Estée Lauder Companies (EL), along with its Beauty Reimagined turnaround efforts and the appointment of Daisy Edgar-Jones as global brand ambassador, have drawn fresh attention to the stock.

Those upgrades and brand moves have arrived alongside stronger trading momentum, with a 90-day share price return of 21.10% and a 1-year total shareholder return of 58.93%, even though the 3-year and 5-year total shareholder returns remain sharply negative.

If Estée Lauder’s turnaround story has your attention, it could be a good moment to broaden your watchlist with healthcare stocks that are also reshaping how consumers think about wellness and beauty.

After a 58.93% 1-year total return and a recent analyst price target of US$106.54 versus a last close of US$115.37, the key question is whether Estée Lauder still offers upside or if the market is already pricing in the turnaround story.

Most Popular Narrative: 10.6% Overvalued

Compared with the last close at US$115.37, the widely followed narrative fair value of about US$104.30 points to a richer market price and a demanding setup.

Significant investment is being allocated to product innovation across prestige price tiers, with a focus on clinically-backed and trend-driven skincare, makeup, and luxury fragrance launches; innovation is targeted to exceed 25% of sales in fiscal '26, and faster time-to-market is being emphasized, which is likely to enhance premium pricing power, brand equity, and gross margins.

Curious how modest revenue growth, margin rebuild and a higher future earnings multiple combine to justify that fair value? The narrative leans on specific earnings, cash flow and discount rate assumptions that could materially change the implied upside. The full story connects those moving parts in a way the current share price already seems to test.

Result: Fair Value of $104.30 (OVERVALUED)

However, the narrative still leans on a rebound in key channels and regions, while prolonged travel retail softness and overexposure to China could easily undermine those assumptions.

Build Your Own Estée Lauder Companies Narrative

If you see the numbers differently or prefer to weigh the data yourself, you can build a custom story in just a few minutes by starting with Do it your way.

A great starting point for your Estée Lauder Companies research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If Estée Lauder is already on your radar, now is a good time to widen your opportunity set and let data rich stock ideas come to you.

• Spot early stage potential with these 3534 penny stocks with strong financials that combine smaller market caps with financial foundations you can actually assess.
• Tap into growth themes by scanning these 25 AI penny stocks that connect artificial intelligence trends with listed businesses you can research in detail.
• Zero in on value oriented setups using these 885 undervalued stocks based on cash flows where prices and cash flow estimates tell a different story from the headline share price.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.